Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 15;20(11):714.
doi: 10.3390/md20110714.

Structural Characterization and In Vivo Anti-Inflammatory Activity of Fucoidan from Cystoseira crinita (Desf.) Borry

Affiliations

Structural Characterization and In Vivo Anti-Inflammatory Activity of Fucoidan from Cystoseira crinita (Desf.) Borry

Elisaveta Apostolova et al. Mar Drugs. .

Abstract

The aim of this study was to evaluate the effects of fucoidan isolated from C. crinita on histamine-induced paw inflammation in rats, and on the serum levels of TNF-α, IL-1β, IL-6, and IL-10 in rats during systemic inflammation response. The levels of TNF-α in a model of acute peritonitis in rats were also investigated. The isolated crude fucoidan was identified as a sulfated xylogalactofucan with high, medium, and low molecular weight fractions and a content of fucose of 39.74%, xylose of 20.75%, and galactose of 15.51%. Fucoidan from C. crinita showed better anti-inflammatory effects in the rat paw edema model, and this effect was present during all stages of the experiment. When compared to controls, a commercial fucoidan from F. vesiculosus, the results also displayed anti-inflammatory activity on the 60th, 90th, and 120th minute of the experiment. A significant decrease in serum levels of IL-1β in rats treated with both doses of C. crinita fucoidan was observed in comparison to controls, whereas TNF-α concentrations were reduced only in the group treated with fucoidan from C. crinita at the dose of 25 mg/kg bw. In the model of carrageenan-induced peritonitis, we observed a tendency of decrease in the levels of the pro-inflammatory cytokine TNF-α in peritoneal fluid after a single dose of C. crinita fucoidan, but this did not reach the statistical significance margin. Single doses of C. crinita fucoidan did not alter serum levels of the anti-inflammatory cytokine IL-10 in animals with lipopolysaccharide-induced systemic inflammation.

Keywords: Cystoseira crinita; IL-1β; TNF-α; anti-inflammatory effect; cytokines; fucoidan; peritonitis; rat paw edema.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
FTIR of fucoidan extracted from C. crinita.
Figure 2
Figure 2
1H NMR spectra of the sulfated fucoidan polysaccharides (a) C. crinita crude fucoidan and (b) commercial standard fucoidan from F. vesiculosus at 80 °C in D2O solution.
Figure 3
Figure 3
SEC-MALS chromatogram of C. crinita crude fucoidan giving Mw (g/mol) versus V (mL) (black), RI signal (blue), and light scattering at 90° (red).
Figure 4
Figure 4
Effects of diclofenac, fucoidan standard from F.vesiculosus (50 mg/kg bw), and fucoidan test from C. crinita (25 and 50 mg/kg bw) on paw edema induced by histamine in rats. * p < 0.05 vs. controls at the same time; ** p < 0.01 vs. controls at the same time; *** p < 0.001 vs. controls at the same time; # p < 0.05 vs. diclofenac at the same time; ## p < 0.01 vs. diclofenac at the same time.
Figure 5
Figure 5
Effect of a single application of fucoidan from C. crinita (25 and 50 mg/kg bw) on serum levels of the pro-inflammatory cytokines IL-1β (panel A), TNF-α (panel B), and Il-6 (panel C) in LPS-induced systemic inflammation in rats. * p < 0.05 vs. same cytokine controls; ** p < 0.01 vs. same cytokine controls; *** p < 0.001 vs. same cytokine controls.
Figure 6
Figure 6
Effect of a single application of dexamethasone (0.2 mg/kg bw) and fucoidan from C. crinita (25 mg/kg bw) on the levels of TNF-α in the peritoneal fluid of rats with carrageenan-induced peritonitis. ** p < 0.01 vs. saline-treated controls.
Figure 7
Figure 7
Effects of a single dose of fucoidan from C. crinita (25 and 50 mg/kg bw) on serum levels of IL-10 in rats with LPS-induced systemic inflammation.
Figure 8
Figure 8
Macrosopic identification of Cystoseira crinita (Desf.) Bory.
Figure 9
Figure 9
Extraction process of fucoidan from C. crinita.

Similar articles

Cited by

References

    1. Jeong J.W., Hwang S.J., Han M.H., Lee D.S., Yoo J.S., Choi I.W., Cha H.J., Kim S., Kim H.S., Kim G.Y., et al. Fucoidan inhibits lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages and zebrafish larvae. Mol. Cell. Toxicol. 2017;13:405–417. doi: 10.1007/s13273-017-0045-2. - DOI
    1. Muralidharan S., Mandrekar P. Cellular stress response and innate immune signaling: Integrating pathways in host defense and inflammation. J. Leukoc. Biol. 2013;94:1167–1184. doi: 10.1189/jlb.0313153. - DOI - PMC - PubMed
    1. Kennedy M.A. A brief review of the basics of immunology: The innate and adaptive response. Vet. Clin. N. Am. Small Anim. Pract. 2010;40:369–379. doi: 10.1016/j.cvsm.2010.01.003. - DOI - PubMed
    1. Kyung J., Kim D., Park D., Yang Y.H., Choi E.K., Lee S.P., Kim T.S., Lee Y.B., Kim Y.B. Synergistic anti-inflammatory effects of Laminaria japonica fucoidan and Cistanche tubulosa extract. Lab. Anim. Res. 2012;28:91–97. doi: 10.5625/lar.2012.28.2.91. - DOI - PMC - PubMed
    1. Wang Y., Xing M., Cao Q., Ji A., Liang H., Song S. Biological activities of fucoidan and the factors mediating its therapeutic effects: A review of recent studies. Mar. Drugs. 2019;17:183. doi: 10.3390/md17030183. - DOI - PMC - PubMed

Grants and funding

This research was funded by Medical University–Plovdiv through the Doctoral and Postdoctoral project-02/2019. The APC was funded by the same institution.

LinkOut - more resources